Insulin-like growth factor receptor I targeting in epithelial ovarian cancer
Authors:
- Walter H. GotliebWGWalter H. Gotlieb
- Ilan BruchimIBIlan Bruchim
- Jing GuJGJing Gu
- Ying ShiYSYing Shi
- Anne CamirandACAnne Camirand
- Marie-José BlouinMBMarie-José Blouin
- Yunhua ZhaoYZYunhua Zhao
- Michael N. PollakMPMichael N. Pollak
- 1 February 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (2) , 389-396
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinaseCancer Cell, 2004
- Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsCancer Cell, 2004
- Drug resistance reversal—are we getting closer?European Journal of Cancer, 2003
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Emerging treatments for ovarian cancerExpert Opinion on Emerging Drugs, 2003
- The insulin-like growth factor insulin system in epithelial ovarian cancerFrontiers in Bioscience-Landmark, 2003
- Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancerInternational Journal of Cancer, 2002
- Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor SystemExperimental Cell Research, 1998
- Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome InactivationJNCI: Journal of the National Cancer Institute, 1992